We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
-0.49%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$627M
AUM Growth
-$2.47M
Cap. Flow
+$2.94M
Cap. Flow %
0.47%
Top 10 Hldgs %
57.65%
Holding
461
New
41
Increased
97
Reduced
56
Closed
19

Top Buys

Rank Stock Value
1
SPTM icon
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
+$4.85M
2
MGC icon
Vanguard Morningstar Mega Cap ETF
MGC
+$2.69M
3
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$1.09M
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$671K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$647K

Top Sells

Rank Stock Value
1
ICSH icon
iShares Ultra Short Duration Bond Active ETF
ICSH
+$2.91M
2
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$1.92M
3
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$779K
4
AMAT icon
Applied Materials
AMAT
+$760K
5
VYMI icon
Vanguard International High Dividend Yield ETF
VYMI
+$755K

Sector Composition

Rank Sector Weight
1 Technology 1.56%
2 Financials 1.33%
3 Consumer Discretionary 0.83%
4 Healthcare 0.42%
5 Energy 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVO
201
Novo Nordisk
NVO
$209B
$30K ﹤0.01%
433
– –
VSGX icon
202
Vanguard ESG International Stock ETF
VSGX
$6.74B
$30K ﹤0.01%
509
– –
CME icon
203
CME Group
CME
$94.8B
$29K ﹤0.01%
110
+10
+10% +$2.47K
D icon
204
Dominion Energy
D
$59.3B
$28K ﹤0.01%
500
– –
NOC icon
205
Northrop Grumman
NOC
$81.2B
$28K ﹤0.01%
54
– –
GSK icon
206
GSK
GSK
$106B
$27K ﹤0.01%
685
– –
VTV icon
207
Vanguard Morningstar Value ETF
VTV
$191B
$26K ﹤0.01%
150
– –
MAR icon
208
Marriott International
MAR
$92.3B
$25K ﹤0.01%
104
– –
APO icon
209
Apollo Global Management
APO
$73.4B
$24K ﹤0.01%
176
– –
AVGO icon
210
Broadcom
AVGO
$2.04T
$24K ﹤0.01%
145
-45
-24% -$9.52K
GILD icon
211
Gilead Sciences
GILD
$165B
$24K ﹤0.01%
218
– –
WMB icon
212
Williams Companies
WMB
$86.1B
$24K ﹤0.01%
400
– –
AZN icon
213
AstraZeneca
AZN
$250B
$23K ﹤0.01%
157
– –
BKNG icon
214
Booking.com
BKNG
$161B
$23K ﹤0.01%
125
– –
VGT icon
215
Vanguard Information Technology ETF
VGT
$149B
$23K ﹤0.01%
336
– –
AEP icon
216
American Electric Power
AEP
$68.4B
$22K ﹤0.01%
200
– –
DFS
217
DELISTED
Discover Financial Services
DFS
$22K ﹤0.01%
129
– –
PAYC icon
218
Paycom
PAYC
$9.69B
$22K ﹤0.01%
102
– –
CLF icon
219
Cleveland-Cliffs
CLF
$6.99B
$21K ﹤0.01%
2,561
– –
CTSH icon
220
Cognizant
CTSH
$26B
$21K ﹤0.01%
270
– –
INTC icon
221
Intel
INTC
$513B
$21K ﹤0.01%
910
– –
MNST icon
222
Monster Beverage
MNST
$88.5B
$21K ﹤0.01%
360
– –
MCHP icon
223
Microchip Technology
MCHP
$46B
$20K ﹤0.01%
408
– –
ATO icon
224
Atmos Energy
ATO
$28.8B
$19K ﹤0.01%
120
– –
WM icon
225
Waste Management
WM
$91B
$19K ﹤0.01%
84
– –
7 8
9
10 11

Similar funds

ICM
Innovator Capital Management Wheaton, Illinois $925M AUM 49.11% 1-Year Est. Return
TC
Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return
CFA
Cahill Financial Advisors Edina, Minnesota $924M AUM 16.55% 1-Year Est. Return
GFG
Goldstone Financial Group Oakbrook Terrace, Illinois $922M AUM 14.34% 1-Year Est. Return
KI
Koch Inc Wichita, Kansas $922M AUM 16.65% 1-Year Est. Return
WC
Westerkirk Capital Victoria $929M AUM 21.93% 1-Year Est. Return
BCC
Biglari Capital Corp San Antonio, Texas $929M AUM 39.8% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

Roble Belko & Company's Q1 2025 Portfolio in Review

As of Q1 2025, Roble Belko & Company held 461 positions worth $627M, down 0.39% from $629M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Roble Belko & Company's Q1 2025 filing shows 41 new, 97 increased, 56 reduced and 19 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 1,850 shares worth $470K. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $2.91M.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 1.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roble Belko & Company's largest Q1 2025 buy was Vanguard Russell 1000 ETF: 1,850 shares worth $470K.
  • Roble Belko & Company added most to State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF in Q1 2025, an estimated $4.85M increase.
  • Roble Belko & Company's biggest Q1 2025 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $2.91M.
  • Roble Belko & Company fully exited iShares 7-10 Year Treasury Bond ETF in Q1 2025, selling an estimated $392K.
  • Roble Belko & Company's ten largest holdings make up 58% of its $627M portfolio in Q1 2025.
  • Roble Belko & Company opened 41 new positions and closed 19 in Q1 2025.
  • Roble Belko & Company's portfolio value fell 0.39% quarter-over-quarter to $627M.

Based on Roble Belko & Company's 13F filing for Q1 2025, filed 8 May 2025.